Dawn E. Telford

2.4k total citations
45 papers, 2.1k citations indexed

About

Dawn E. Telford is a scholar working on Surgery, Molecular Biology and Epidemiology. According to data from OpenAlex, Dawn E. Telford has authored 45 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Surgery, 21 papers in Molecular Biology and 12 papers in Epidemiology. Recurrent topics in Dawn E. Telford's work include Cholesterol and Lipid Metabolism (22 papers), Lipoproteins and Cardiovascular Health (12 papers) and Peroxisome Proliferator-Activated Receptors (10 papers). Dawn E. Telford is often cited by papers focused on Cholesterol and Lipid Metabolism (22 papers), Lipoproteins and Cardiovascular Health (12 papers) and Peroxisome Proliferator-Activated Receptors (10 papers). Dawn E. Telford collaborates with scholars based in Canada, Australia and United States. Dawn E. Telford's co-authors include Murray W. Huff, Jane Y. Edwards, Brian G. Sutherland, Cynthia G. Sawyez, P. Hugh R. Barrett, Amy C. Burke, Erin E. Mulvihill, John R. Burnett, Roger S. Newton and Emma M. Allister and has published in prestigious journals such as Diabetes, Endocrinology and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Dawn E. Telford

45 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dawn E. Telford Canada	27	876	792	548	413	365	45	2.1k
Cynthia G. Sawyez Canada	26	661 0.8×	938 1.2×	473 0.9×	498 1.2×	389 1.1×	44	2.2k
Jane Y. Edwards Canada	21	627 0.7×	760 1.0×	366 0.7×	386 0.9×	318 0.9×	33	1.8k
Fady Ntanios United States	24	1.6k 1.9×	626 0.8×	404 0.7×	215 0.5×	304 0.8×	44	2.5k
Heyao Wang China	30	359 0.4×	1.2k 1.5×	354 0.6×	250 0.6×	156 0.4×	111	2.4k
Khadija Ouguerram France	26	966 1.1×	555 0.7×	641 1.2×	324 0.8×	92 0.3×	101	2.1k
Angelo Maria Patti Italy	26	459 0.5×	506 0.6×	801 1.5×	239 0.6×	150 0.4×	58	1.8k
Yuguang Lin Netherlands	20	708 0.8×	542 0.7×	275 0.5×	182 0.4×	208 0.6×	27	1.5k
Brian G. Sutherland Canada	17	318 0.4×	559 0.7×	324 0.6×	352 0.9×	378 1.0×	35	1.4k
Donald J. McNamara United States	33	1.5k 1.7×	744 0.9×	691 1.3×	373 0.9×	192 0.5×	99	3.2k
Sharon Arrol United Kingdom	29	996 1.1×	550 0.7×	1.0k 1.8×	233 0.6×	362 1.0×	43	4.7k

Countries citing papers authored by Dawn E. Telford

Since Specialization

Citations

This map shows the geographic impact of Dawn E. Telford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn E. Telford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn E. Telford more than expected).

Fields of papers citing papers by Dawn E. Telford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn E. Telford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn E. Telford. The network helps show where Dawn E. Telford may publish in the future.

Co-authorship network of co-authors of Dawn E. Telford

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn E. Telford. A scholar is included among the top collaborators of Dawn E. Telford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn E. Telford. Dawn E. Telford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Burke, Amy C., Andrew Wang, Dawn E. Telford, et al.. (2020). The citrus flavonoid nobiletin confers protection from metabolic dysregulation in high-fat-fed mice independent of AMPK. Journal of Lipid Research. 61(3). 387–402. 50 indexed citations

Burke, Amy C., Brian G. Sutherland, Dawn E. Telford, et al.. (2019). Naringenin enhances the regression of atherosclerosis induced by a chow diet in Ldlr mice. Atherosclerosis. 286. 60–70. 26 indexed citations

Burke, Amy C., Dawn E. Telford, & Murray W. Huff. (2018). Bempedoic acid: effects on lipoprotein metabolism and atherosclerosis. Current Opinion in Lipidology. 30(1). 1–9. 49 indexed citations

Burke, Amy C., Brian G. Sutherland, Dawn E. Telford, et al.. (2018). Intervention with citrus flavonoids reverses obesity and improves metabolic syndrome and atherosclerosis in obese Ldlr−/− mice. Journal of Lipid Research. 59(9). 1714–1728. 99 indexed citations

Burke, Amy C., Dawn E. Telford, Jane Y. Edwards, et al.. (2018). Naringenin Supplementation to a Chow Diet Enhances Energy Expenditure and Fatty Acid Oxidation, and Reduces Adiposity in Ldlr-/- Mice with Isocaloric Food Intake. Atherosclerosis Supplements. 32. 23–23. 1 indexed citations

Burke, Amy C., Brian G. Sutherland, Cynthia G. Sawyez, Dawn E. Telford, & Murray W. Huff. (2016). Abstract 95: Naringenin Supplementation of a Low-Fat Diet Enhances the Reversal of Metabolic Dysfunction, Promotes Atherosclerosis Regression and Improves Lesion Pathology in Ldlr ^-/- Mice. Arteriosclerosis Thrombosis and Vascular Biology. 36(suppl_1). 1 indexed citations

Assini, Julia M., Erin E. Mulvihill, Amy C. Burke, et al.. (2015). Naringenin Prevents Obesity, Hepatic Steatosis, and Glucose Intolerance in Male Mice Independent of Fibroblast Growth Factor 21. Endocrinology. 156(6). 2087–2102. 90 indexed citations

Telford, Dawn E., Morgan D. Fullerton, Rebecca J. Ford, et al.. (2014). PPARδ activation attenuates hepatic steatosis in Ldlr mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity. Journal of Lipid Research. 55(7). 1254–1266. 67 indexed citations

Burke, Amy C., Brian G. Sutherland, Cynthia G. Sawyez, et al.. (2014). Abstract 67: Intervention With Citrus Flavonoids Reverses Existing Metabolic Disorders and Attenuates the Progression of Advanced Atherosclerosis in High Fat--Fed LDLr-/- Mice. Arteriosclerosis Thrombosis and Vascular Biology. 34(suppl_1). 3 indexed citations

10.

Assini, Julia M., Erin E. Mulvihill, Brian G. Sutherland, et al.. (2012). Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr mice. Journal of Lipid Research. 54(3). 711–724. 113 indexed citations

11.

Sawyez, Cynthia G., et al.. (2012). Activation of Peroxisome Proliferator-Activated Receptor δ Inhibits Human Macrophage Foam Cell Formation and the Inflammatory Response Induced by Very Low-Density Lipoprotein. Arteriosclerosis Thrombosis and Vascular Biology. 32(12). 2919–2928. 45 indexed citations

12.

Mulvihill, Erin E., Emma M. Allister, Brian G. Sutherland, et al.. (2009). Naringenin Prevents Dyslipidemia, Apolipoprotein B Overproduction, and Hyperinsulinemia in LDL Receptor–Null Mice With Diet-Induced Insulin Resistance. Diabetes. 58(10). 2198–2210. 250 indexed citations

13.

Telford, Dawn E., Brian G. Sutherland, Jane Y. Edwards, et al.. (2006). The molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatin. Journal of Lipid Research. 48(3). 699–708. 91 indexed citations

14.

Huff, Murray W. & Dawn E. Telford. (2005). Lord of the rings – the mechanism for oxidosqualene:lanosterol cyclase becomes crystal clear. Trends in Pharmacological Sciences. 26(7). 335–340. 69 indexed citations

15.

Telford, Dawn E., P. Hugh R. Barrett, Brian G. Sutherland, et al.. (2005). A Novel Inhibitor of Oxidosqualene:Lanosterol Cyclase Inhibits Very Low–Density Lipoprotein Apolipoprotein B100 (ApoB100) Production and Enhances Low-Density Lipoprotein ApoB100 Catabolism Through Marked Reduction in Hepatic Cholesterol Content. Arteriosclerosis Thrombosis and Vascular Biology. 25(12). 2608–2614. 20 indexed citations

16.

Burnett, John R., et al.. (1998). Inhibition of cholesterol esterification by DuP 128 decreases hepatic apolipoprotein B secretion in vivo: effect of dietary fat and cholesterol. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1393(1). 63–79. 25 indexed citations

17.

Burnett, John R., P. Hugh R. Barrett, Paolo Vicini, et al.. (1998). The HMG-CoA Reductase Inhibitor Atorvastatin Increases the Fractional Clearance Rate of Postprandial Triglyceride-Rich Lipoproteins in Miniature Pigs. Arteriosclerosis Thrombosis and Vascular Biology. 18(12). 1906–1914. 33 indexed citations

18.

Huff, Murray W., Dawn E. Telford, Brian Edmonds, Charlotte McDonald, & Andrew J. Evans. (1993). Lipoprotein lipases, lipoprotein density gradient profile and LDL receptor activity in miniature pigs fed fish oil and corn oil. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1210(1). 113–122. 32 indexed citations

19.

Huff, Murray W. & Dawn E. Telford. (1989). Regulation of low density lipoprotein apoprotein B metabolism by lovastatin and cholestyramine in miniature pigs: Effects on LDL composition and synthesis of LDL subfractions. Metabolism. 38(3). 256–264. 32 indexed citations

20.

Huff, Murray W. & Dawn E. Telford. (1985). Direct synthesis of low-density lipoprotein apoprotein B in the miniature pig. Metabolism. 34(1). 36–42. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact